Gold prices buoyed by tariff fears; US duties on 1-kilo bars spur supply concerns
Leslie D. Funtleyder, the Interim Chief Executive Officer and Chief Financial Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), recently sold 14,502 shares of the company’s common stock. The transaction, which took place on March 4, 2025, was executed at a price of $0.44 per share, resulting in a total sale value of $6,380. The sale comes as APLT’s stock has experienced significant volatility, with shares down over 90% in the past year and currently trading near its 52-week low of $0.43.
According to the filing, the sale was conducted to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units. This transaction was a "sell to cover" action and was not a discretionary sale by Funtleyder. Following this sale, Funtleyder retains ownership of 390,459 shares in the company. InvestingPro data shows the company maintains a relatively healthy balance sheet with more cash than debt, though analysts have recently revised earnings expectations downward.
Applied Therapeutics is a pharmaceutical company headquartered in New York, known for its work in developing treatments for diseases with significant unmet medical needs. According to InvestingPro analysis, the company’s current market capitalization stands at $58 million, with analyst price targets ranging from $1.50 to $13 per share. Get access to 12 more exclusive ProTips and comprehensive financial analysis with an InvestingPro subscription.
In other recent news, Applied Digital Corporation reported fiscal second-quarter results that exceeded analyst expectations. The company achieved adjusted earnings per share of -$0.06, surpassing the consensus estimate of -$0.14. Revenue reached $63.9 million, marking a 51% increase year-over-year and slightly beating the forecast of $63.39 million. A significant contribution came from the Cloud Services segment, which saw a 523% year-over-year revenue increase to $27.7 million. Additionally, Applied Digital’s Data Center Hosting business generated $36.2 million in revenue for the quarter. In a strategic move, the company announced a $5 billion perpetual preferred equity financing facility with Macquarie Asset Management. This agreement is aimed at strengthening its position as a leading high-performance computing data center operator in the U.S. Meanwhile, Applied Therapeutics, Inc. has been notified by the Nasdaq Stock Market of non-compliance with the minimum bid price requirement. The company has a 180-day period to regain compliance or risk delisting, and it is currently evaluating its options.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.